The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition

Ron Danziger(Stanford University), Maya Koronyo‐Hamaoui(Cedars-Sinai Medical Center), Keith L. Black(Cedars-Sinai Medical Center), Altan Rentsendorj(Cedars-Sinai Medical Center), Sébastien Fuchs(Cedars-Sinai Medical Center), Dieu‐Trang Fuchs(Cedars-Sinai Medical Center), Julia Sheyn(Cedars-Sinai Medical Center), Eric Y. Hayden(University of California, Los Angeles), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Yosef Koronyo(Cedars-Sinai Medical Center), David B. Teplow(University of California, Los Angeles)
Frontiers in Physiology
June 23, 2023
10.3389/fphys.2023.1179315
Cited by 13

Related Papers

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
|Science|1999|3.8k
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
|Nature|1991|1.3k
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
|Nature|1995|745
Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis11Edited by F. Cohen
|Journal of Molecular Biology|2001|684
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533